SCI时时刷

search
Which is older, Medicine or Wine?
Which is older, Medicine or Wine?
Wine is the most remarkable of Medicines. Where Wine is lacking Medicine is necessary. ...
Human-in-the-loop avatar chatbot shows promise in supporting hematopoietic stem cell transplantation patients
Authors and AffiliationsDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USAAmar H. Kelkar, Nicho...
Construction of a digital twin of chronic graft vs. host disease patients with standard of care
Construction of a digital twin of chronic graft vs. host disease patients with standard of care
There is an unmet medical need for new clinical trials to evaluate novel therapies in chronic graft-versus-host disease (c...
Monocytosis as prognostic factor for chronic graft versus host disease
Monocytosis as prognostic factor for chronic graft versus host disease
Chronic graft versus host disease (cGvHD) is the main cause of long-term morbidity and mortality after allogeneic hematopo...
Disparities in access to hematopoietic cell transplant persist at a transplant center
Disparities in access to hematopoietic cell transplant persist at a transplant center
Disparities in access to hematopoietic cell transplant (HCT) are well established. Prior studies have identified barriers,...
Blood transfusion, alcohol abuse and altruism
Blood transfusion, alcohol abuse and altruism
A bottle of wine contains more philosophy than all the books in the world. Lou...
Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
Línia de recerca d’Oncologia i Hematologia, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Ba...
Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis
Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis
Jones RJ. Haploidentical transplantation: repurposing cyclophosphamide. Biol Blood Marrow Transpl. 2012;18:1771–2.Article ...
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies
Disease recurrence remains the principal cause of treatment failure after allogeneic hematopoietic stem cell transplantati...
Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation
Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation
Annaloro C, Serpenti F, Saporiti G, Galassi G, Cavallaro F, Grifoni F, et al. Viral Infections in HSCT: Detection, Monitor...
Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia
Heinicke T, Labopin M, Polge E, Stelljes M, Ganser A, Tischer J, et al. Evaluation of six different types of sequential co...